NEI
BSX icon

Northwest & Ethical Investments’s Boston Scientific BSX Stock Holding History

Northwest & Ethical Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$800K Sell
18,746
-62,436
-77% -$3.39M 0.02% 304
2026
Q1 		$5.09M Sell
81,182
-3,970
-5% -$318K 0.12% 164
2025
Q4 		$8.13M Buy
85,152
+5,021
+6% +$492K 0.18% 133
2025
Q3 		$7.81M Buy
80,131
+7,581
+10% +$785K 0.18% 140
2025
Q2 		$7.78M Sell
72,550
-1,800
-2% -$182K 0.19% 141
2025
Q1 		$7.5M Sell
74,350
-78
-0.1% -$7.85K 0.2% 142
2024
Q4 		$6.65M Buy
74,428
+330
+0.4% +$29.1K 0.18% 162
2024
Q3 		$6.21M Buy
74,098
+35,336
+91% +$2.79M 0.16% 163
2024
Q2 		$2.99M Buy
38,762
+33,366
+618% +$2.44M 0.09% 212
2024
Q1 		$370K Buy
+5,396
New +$347K 0.01% 358
2017
Q3 		– Sell
-5,138
Closed -$142K – 353
2017
Q2 		$142K Buy
5,138
+900
+21% +$23.9K 0.01% 331
2017
Q1 		$105K Sell
4,238
-1,600
-27% -$38.9K 0.01% 348
2016
Q4 		$126K Buy
+5,838
New +$127K 0.01% 342

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northwest & Ethical Investments's BSX Position: Q2 2026 in Review

Northwest & Ethical Investments reduced its Boston Scientific (BSX) stake by 77% in Q2 2026, selling an estimated $3.39M and leaving 18,746 shares worth $800K. The position accounts for 0.02% of the portfolio, ranked #304.

Northwest & Ethical Investments first reported a position in BSX in Q4 2016 and has held it in 13 quarters since. The position peaked at $8.13M in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Northwest & Ethical Investments held 18,746 shares of Boston Scientific worth $800K as of Q2 2026.
  • Northwest & Ethical Investments sold 62,436 Boston Scientific shares in Q2 2026, an estimated $3.39M.
  • Boston Scientific made up 0.02% of Northwest & Ethical Investments's portfolio in Q2 2026, its #304 holding.
  • Northwest & Ethical Investments first reported a position in Boston Scientific in Q4 2016 and has held it in 13 quarters since.
  • Northwest & Ethical Investments's Boston Scientific position peaked at $8.13M in Q4 2025.
  • 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Northwest & Ethical Investments's 13F filing for Q2 2026, filed 13 Aug 2026.